首页> 外文期刊>Bone marrow transplantation >Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML.
【24h】

Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML.

机译:Ig样杀伤受体(KIR)的相容性在无关的AML造血细胞移植中在急性GVHD的流行中发挥作用。

获取原文
获取原文并翻译 | 示例
       

摘要

Killer Ig-like receptor (KIR) is a major cluster of the natural killer cell receptors and may play a role in the outcome of hematopoietic cell transplants. A total of 65 AML cases transplanted with T-replete hematopoietic cells from unrelated donors were retrospectively KIR-genotyped by a multiplex PCR method of our own design. The KIR gene frequency and genotype patterns in these 130 samples were consistent with the data in the literature. Based upon overall inhibitory and activating KIR genes in both donors and patients, we developed an algorithm to calculate a compatibility score for each transplant case as plus, zero or minus. Significantly higher incidence (18/20, 90%) of acute (a) GVHD (grade II-IV) was found in the transplant cases with plus scores than that (25/45, 56%) in the cases with zero or minus scores (P < 0.01). When the scores are sorted in the opposite way, fewer cases (13/26, 50%) of aGVHD were found in the transplants with minus scores than that (30/39, 77%) in the transplants with zero or plus scores (P < 0.05). The difference of aGVHD prevalence between the plus score and minus score groups is highly significant (P < 0.01). KIR genotype compatibility calculated by this algorithm may predict aGVHD incidence and be helpful in choosing donors.
机译:Ig样杀手受体(KIR)是自然杀伤细胞受体的主要组成部分,可能在造血细胞移植的结果中起作用。通过我们自己设计的多重PCR方法,回顾性分析了共65例移植有来自无关供体的T型造血细胞的AML病例。这130个样本中的KIR基因频率和基因型模式与文献数据一致。基于供体和患者的总体抑制和激活KIR基因,我们开发了一种算法,计算每个移植病例的相容性得分为正,零或负。分数为零或减分的移植患者中,急性(a)GVHD(II-IV级)的发生率显着更高(25 / 45,56%),发生率(18 / 20,90%) (P <0.01)。当分数以相反的方式排序时,带有负分数的移植物中发现的aGVHD的病例少于具有零或正分数(P的移植)中的aGVHD病例(30/39,77%) <0.05)。加分组和减分组之间的aGVHD患病率差异非常显着(P <0.01)。通过该算法计算的KIR基因型相容性可以预测aGVHD发生率,并有助于选择供体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号